Hemoglobinuria (hemoglobin in the urine)
- Understanding Hemoglobinuria (Hemoglobin in the Urine)
- Causes of Intravascular Hemolysis Leading to Hemoglobinuria
- Clinical Manifestations and Associated Symptoms
- Diagnosis of Hemoglobinuria and Intravascular Hemolysis
- Differential Diagnosis of Red or Dark Brown Urine
- Management and Treatment of Hemoglobinuria
- Potential Complications of Hemoglobinuria
- When to Seek Medical Attention
- References
Understanding Hemoglobinuria (Hemoglobin in the Urine)
Hemoglobinuria is a condition characterized by the presence of free hemoglobin in the urine. This is a significant clinical finding as it indicates **intravascular hemolysis**, which is the premature destruction of red blood cells (erythrocytes) within the bloodstream, as opposed to extravascular hemolysis which occurs within the spleen, liver, or bone marrow. When hemoglobinuria occurs, the urine typically appears dark red or dark brown, sometimes described as "cola-colored" or "tea-colored." The presence of hemoglobinuria is always preceded by **hemoglobinemia**, which is an excess of free hemoglobin in the blood plasma.
Definition and Pathophysiology
Hemoglobin is the iron-containing protein within red blood cells responsible for oxygen transport. When red blood cells lyse (break apart) within blood vessels, hemoglobin is released into the plasma.
Role of Haptoglobin and Renal Handling of Hemoglobin
In a healthy individual, a small percentage (about 10%) of aging erythrocytes are naturally destroyed within the bloodstream. The plasma normally contains a very low concentration of free hemoglobin, not exceeding 4 mg% (or 0.04 g/L). This free hemoglobin in the blood is promptly bound by a specific plasma protein called **haptoglobin**. The haptoglobin-hemoglobin complex is a large molecule (molecular weight of 160-320 kDa) that is too large to pass through the renal glomerular filter. Instead, this complex is cleared from circulation by the reticuloendothelial system (also known as the mononuclear phagocyte system) in the liver and spleen, where it undergoes cleavage to form the end products of pigment metabolism (bilirubin, iron, etc.).
Hemoglobinuria occurs only when the rate of intravascular hemolysis is so great that the amount of free hemoglobin released into the plasma exceeds the binding capacity of haptoglobin. At a normal blood haptoglobin concentration, its reserve binding capacity for hemoglobin is approximately 100 mg% (or 1 g/L). When plasma free hemoglobin levels surpass this threshold, unbound hemoglobin (which has a smaller molecular weight of about 64.5 kDa) can pass through the glomerular filter into the renal tubules.
The intensity of hemoglobinuria is influenced by several factors:
- The degree of hemoglobinemia (concentration of free hemoglobin in plasma).
- The concentration of haptoglobin in the blood (if haptoglobin levels are low, e.g., due to chronic hemolysis or genetic deficiency, hemoglobinuria can appear with less severe hemoglobinemia).
- The reabsorptive capacity of the renal tubules for hemoglobin.
With a low plasma haptoglobin level, hemoglobinuria can manifest without exceptionally high levels of hemoglobinemia.
Hemosiderinuria as an Indicator
When hemoglobinemia exceeds approximately 100-120 mg%, there is an increased reabsorption of filtered hemoglobin by the epithelial cells of the renal tubules, particularly the proximal tubules. Within these cells, the reabsorbed hemoglobin is oxidized and broken down, and its iron is stored as **hemosiderin** and **ferritin**. When these hemosiderin-laden tubular cells are shed (exfoliated) into the urine, they can be detected microscopically (hemosiderinuria). With a large amount of hemosiderin processing, free-lying hemosiderin granules (detected by Prussian blue stain) can also be found in the urine sediment. Therefore, hemoglobinemia exceeding 125 mg% is often accompanied by both hemosiderinuria and hemoglobinuria.
Thus, key laboratory signs indicating intravascular hemolysis include hemoglobinemia (low haptoglobin, elevated plasma free hemoglobin), hemoglobinuria, and hemosiderinuria.
Causes of Intravascular Hemolysis Leading to Hemoglobinuria
Intravascular hemolysis, the underlying cause of hemoglobinuria, can result from a variety of inherited and acquired conditions:
Inherited Conditions
- Paroxysmal Nocturnal Hemoglobinuria (PNH) (Markiafava-Micheli disease): A rare, acquired clonal stem cell disorder resulting in red blood cells that are abnormally sensitive to complement-mediated destruction.
- Sickle Cell Hemoglobinopathy (Sickle Cell Anemia): While primarily causing extravascular hemolysis, significant intravascular hemolysis can occur during vaso-occlusive crises.
- Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency: An enzyme defect that makes red blood cells susceptible to oxidative stress and hemolysis when exposed to certain drugs, infections, or fava beans.
- Other Red Blood Cell Enzyme Deficiencies (e.g., pyruvate kinase deficiency).
- Unstable Hemoglobins.
- Thalassemias (severe forms): Can have an intravascular component.
Acquired Conditions
- Autoimmune Hemolytic Anemias (AIHA): Especially those mediated by cold agglutinins (IgM antibodies) or complement-fixing IgG antibodies that cause intravascular lysis.
- Post-Transfusion Hemolytic Reactions: Due to ABO incompatibility or other alloantibodies causing rapid destruction of transfused red blood cells.
- Drug-Induced Hemolysis: Certain medications can cause immune-mediated hemolysis or direct oxidative damage.
- Infections:
- Blood Parasites (Malaria): Particularly *Plasmodium falciparum* infection can cause severe intravascular hemolysis ("blackwater fever").
- Clostridial sepsis (e.g., *Clostridium perfringens*).
- Other severe bacterial or viral infections.
- Mechanical Trauma to Red Blood Cells:
- Prosthetic heart valves (especially older or malfunctioning ones).
- March hemoglobinuria (due to repetitive foot strike impact, e.g., in long-distance runners).
- Disseminated Intravascular Coagulation (DIC).
- Thrombotic Thrombocytopenic Purpura (TTP) / Hemolytic Uremic Syndrome (HUS).
- Toxins and Venoms:
- Poisoning with snake venom, spider bites.
- Chemicals like phenylhydrazine, arsine gas, copper, lead.
- Severe Burns: Extensive thermal injury can damage red blood cells directly.
- Malignant Tumors: Rarely, some cancers can be associated with microangiopathic hemolytic anemia or autoimmune hemolysis.
- Avitaminosis (Severe Deficiencies): While not a direct cause of intravascular hemolysis, severe nutritional deficiencies might impair RBC integrity, though this is less common as a primary cause of significant hemoglobinuria compared to direct hemolytic processes. The original text mentions "avitaminosis" broadly.
Clinical Manifestations and Associated Symptoms
Hemoglobinuria itself causes the urine to appear dark red-brown. Other symptoms are related to the underlying intravascular hemolysis and its severity:
- Symptoms of Anemia: Fatigue, weakness, pallor, shortness of breath, dizziness, palpitations.
- Jaundice: Yellowing of the skin and eyes due to increased bilirubin production from hemoglobin breakdown (more prominent in extravascular hemolysis but can occur with significant intravascular hemolysis).
- Abdominal Pain or Back Pain: Can occur during acute hemolytic episodes.
- Fever and Chills: Especially if hemolysis is due to infection or transfusion reaction.
- Splenomegaly: Enlargement of the spleen may be present in some chronic hemolytic conditions.
- Symptoms specific to the underlying cause: E.g., thrombotic events in PNH, vaso-occlusive pain in sickle cell disease.
- Acute Kidney Injury (AKI): Free hemoglobin is nephrotoxic and can cause acute tubular necrosis, especially if hemolysis is massive or if there is pre-existing renal compromise or dehydration. This can lead to oliguria (decreased urine output) or anuria (no urine output).
Diagnosis of Hemoglobinuria and Intravascular Hemolysis
The diagnostic workup aims to confirm hemoglobinuria, distinguish it from hematuria (intact red blood cells in urine), and identify the cause of intravascular hemolysis.
- Urinalysis:
- Appearance: Dark red, brown, or "cola-colored" urine.
- Dipstick Test for Blood: Will be positive due to the presence of heme (from hemoglobin).
- Microscopic Examination: Crucially, few or no intact red blood cells will be seen in true hemoglobinuria, differentiating it from hematuria. Hemoglobin casts may be present. Hemosiderin may be detected in shed tubular cells or as free granules with special stains (Prussian blue) in chronic hemolysis.
- Blood Tests:
- Complete Blood Count (CBC): To assess for anemia, reticulocytosis (increased young red blood cells, indicating bone marrow response to hemolysis).
- Peripheral Blood Smear: To look for abnormal red blood cell morphology (e.g., schistocytes in microangiopathic hemolysis, spherocytes in some AIHAs, sickle cells).
- Plasma Free Hemoglobin: Elevated.
- Serum Haptoglobin: Decreased or absent, as it is consumed by binding free hemoglobin.
- Lactate Dehydrogenase (LDH): Elevated (released from hemolyzed red blood cells).
- Indirect Bilirubin: Elevated due to increased hemoglobin breakdown.
- Direct Antiglobulin Test (DAT or Coombs Test): To detect antibodies on red blood cells in immune-mediated hemolysis.
- Renal Function Tests (Creatinine, BUN): To assess for kidney damage.
- Specific tests based on clinical suspicion: E.g., G6PD enzyme assay, hemoglobin electrophoresis (for sickle cell, thalassemias), PNH flow cytometry, malaria smear, toxicology screen.
Differential Diagnosis of Red or Dark Brown Urine
It's important to differentiate true hemoglobinuria from other causes of discolored urine:
Condition | Urine Dipstick for Blood | Urine Microscopy | Other Key Features |
---|---|---|---|
Hemoglobinuria | Positive | Few or no RBCs; hemoglobin casts may be present; hemosiderin (chronic) | Signs of intravascular hemolysis (low haptoglobin, high LDH, high plasma free Hb). |
Hematuria (Intact RBCs) | Positive | Many RBCs present; RBC casts if glomerular origin. | Source of bleeding in urinary tract (glomerular, renal, or post-renal). Plasma clear. |
Myoglobinuria | Positive (myoglobin also contains heme) | Few or no RBCs; myoglobin casts may be present. | History of muscle injury/rhabdomyolysis (trauma, crush injury, extreme exertion, certain drugs/toxins). Elevated serum creatine kinase (CK). Plasma clear. |
Porphyria | Negative (usually) | Normal | Urine may turn dark (port-wine color) on standing/exposure to light. Abdominal pain, neurological/psychiatric symptoms. Specific tests for porphyrins. |
Bilirubinuria/Urobilinogenuria | Negative | Bilirubin crystals may be present. | Dark yellow or brown urine ("tea-colored"). Associated with liver disease or biliary obstruction. Positive bilirubin on dipstick. |
Medications | Variable (usually negative unless causing hematuria/hemoglobinuria) | Usually normal | Certain drugs can color urine red/orange/brown (e.g., rifampin, phenazopyridine, senna, metronidazole). |
Foods | Negative | Normal | Beets, blackberries, rhubarb can cause reddish urine. |
Management and Treatment of Hemoglobinuria
The management of hemoglobinuria is directed at treating the underlying cause of the intravascular hemolysis and preventing or managing complications, particularly acute kidney injury.
- Identify and Treat the Underlying Cause: This is paramount. Examples include:
- Discontinuing offending drugs in drug-induced hemolysis.
- Immunosuppression for autoimmune hemolytic anemia.
- Specific therapies for PNH (e.g., eculizumab).
- Treatment of infections (e.g., antimalarials for malaria).
- Management of sickle cell crises.
- Supportive care for G6PD deficiency crises (avoiding triggers, hydration).
- Antidotes or specific treatments for poisonings.
- Supportive Care for Hemolysis:
- Hydration: Intravenous fluids are often crucial, especially in acute, severe hemolysis, to maintain renal perfusion and help flush hemoglobin through the kidneys, reducing the risk of tubular damage.
- Blood Transfusion: May be needed for severe anemia, but must be done cautiously, especially if an immune cause is suspected (risk of further hemolysis). Compatible blood is essential.
- Folic Acid Supplementation: Chronic hemolysis increases folate demand for red blood cell production.
- Prevention/Management of Acute Kidney Injury (AKI):
- Aggressive hydration.
- Urine alkalinization (e.g., with sodium bicarbonate) has been used in some settings with the aim of reducing hemoglobin precipitation in tubules, but its efficacy is debated and not universally recommended.
- Diuretics may be used if fluid overload occurs, but only after adequate intravascular volume is restored.
- Dialysis may be required if severe AKI develops.
Potential Complications of Hemoglobinuria
The main complication of significant hemoglobinuria is **acute kidney injury (AKI)** due to the nephrotoxic effects of free hemoglobin on renal tubules (acute tubular necrosis). Other complications are related to the underlying hemolytic process and its severity:
- Severe anemia and its consequences (cardiac strain, hypoxia).
- Iron overload (from chronic hemolysis and transfusions, leading to hemosiderosis).
- Thromboembolic events (particularly in PNH and some other hemolytic conditions).
- Gallstones (bilirubin stones from chronic hemolysis).
- Complications specific to the underlying disease (e.g., vaso-occlusive crises in sickle cell disease).
When to Seek Medical Attention
Hemoglobinuria, indicated by dark red or brown urine without visible red blood cells on microscopy, is a serious sign that warrants prompt medical evaluation. Seek medical attention if:
- Urine suddenly becomes dark red, brown, or "cola-colored."
- Symptoms of anemia (fatigue, pallor, shortness of breath) develop.
- Jaundice appears.
- There is unexplained abdominal or back pain.
- Fever, chills, or other signs of infection accompany discolored urine.
- Urine output significantly decreases.
A physician, often a hematologist or nephrologist, will investigate the cause of intravascular hemolysis and initiate appropriate management to prevent kidney damage and treat the underlying disorder.
References
- Bunn HF. Pathogenesis and treatment of Sickle Cell Disease. N Engl J Med. 1997;337(11):762-769. (Context for intravascular hemolysis in specific conditions)
- Hill A, DeZern AE, Kinoshita T, Brodsky RA. Paroxysmal nocturnal haemoglobinuria. Nat Rev Dis Primers. 2017 Apr 6;3:17028.
- Packman CH. Hemolytic anemia due to warm autoantibodies. Blood Rev. 2008 Jan;22(1):17-31.
- Beutler E. G6PD deficiency. Blood. 1994 Dec 1;84(11):3613-36.
- Schrier SL. Pathophysiology of G6PD deficiency. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed on [Current Date]).
- Zantek ND, Kopec JA, Hall S, et al. Acute renal failure due to rhabdomyolysis: a case of march hemoglobinuria. Am J Kidney Dis. 2001;38(3):E10. (Context for exertional hemoglobinuria and AKI)
- Gottschall JL. The ABCs of TTP and HUS. J Clin Apher. 2000;15(3‐4):156-160.
- Rose BD, Rennke HG. Renal Pathophysiology: The Essentials. Williams & Wilkins; 1994. Chapter 6: Acute Renal Failure.
See also
- Benign Prostatic Hyperplasia (BPH)
- Cystitis (Bladder Infection)
- Hydrocele (Testicular Fluid Collection)
- Kidney Stones (Urolithiasis)
- Kidney (Urinary) Syndromes & Urinalysis Findings
- Bilirubinuria and Urobilinogenuria
- Cylindruria (Casts in Urine)
- Glucosuria (Glucose in Urine)
- Hematuria (Blood in Urine)
- Hemoglobinuria (Hemoglobin in Urine)
- Ketonuria (Ketone Bodies in Urine)
- Myoglobinuria (Myoglobin in Urine)
- Proteinuria (Protein in Urine)
- Porphyrinuria (Porphyrins in Urine) & Porphyria
- Pyuria (Leukocyturia - WBCs in Urine)
- Orchitis & Epididymo-orchitis (Testicular Inflammation)
- Prostatitis (Prostate Gland Inflammation)
- Pyelonephritis (Kidney Infection)
- Hydronephrosis & Pyonephrosis
- Varicocele (Enlargement of Spermatic Cord Veins)
- Vesiculitis (Seminal Vesicle Inflammation)